Print

Roadmap to Parenthood: A Study about Fertility and Family-Building After Cancer

https://www.facingourrisk.org/research-clinical-trials/study/302/roadmap-to-parenthood-a-study-about-fertility-and-family-building-after-cancer

Clinicaltrials.gov identifier:
NCT06050135 (https://clinicaltrials.gov/show/NCT06050135)

Surveys, Registries, Interviews
Roadmap to Parenthood is a remote, survey-based study. Eligible participants must be aged 18-45, assigned female at birth, and history of a cancer diagnosis

Study Contact Information:

Research coordinator: Sumitra Ananth

Contact: [email protected]


About the Study

Cancer treatments can cause infertility, early menopause, or problems getting pregnant. Family building after cancer may require reproductive medicine, surrogacy, or adoption. We are conducting this study to evaluate an online tool developed to educate and provide support to women and people assigned female at birth who are interested in family building after cancer. This study involves the completion of four online surveys. All study procedures are done remotely.

What the Study Involves

The Roadmap to Parenthood study is a randomized clinical trial being conducted at Stanford University School of Medicine. We are testing the efficacy of an online “decision aid and planning tool” for family building after cancer. All study participants will complete four online surveys, each of which take 30-45 minutes, over the course of 12 months. Participants will be compensated $30 for the completion of each study survey, receiving a total of $120 for completing all four surveys.

Complete the recruitment form to participate: https://redcap.link/kdxlyxwu

 

Lead Researcher

PI: Catherine Benedict, PhD
Institution: Stanford University School of Medicine
Contact: [email protected]


This Study is Open To:

People who: 

This Study is Not Open To:

People who are currently undergoing chemotherapy, radiation, or planned surgery as primary treatment for cancer


About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.